Insider filing · NBIX
Stephen A Sherwin
Director
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Stephen A Sherwin sold $1.6M of Neurocrine Biosciences (NBIX)
Executed Feb 13 2025, disclosed Feb 14 2025, 1 day later.
Value, as filed
$1.6M
13,831 sh × $116.69
Executed
Feb 13 2025
the trade date, as filed
Disclosed
Feb 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SSStephen A Sherwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $4.1M of NBIX (25,000 sh across 5 lots, as filed), executed Jun 5.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Stephen A Sherwin in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$4.1M25,000 sh across 5 lots
Exec Jun 5
Filed Jun 9 · 5:30 PM ET